AGM.A Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Federal Agricultural Mortgage Corp is a good buy for a beginner-focused, long-term investor with $50,000-$100,000 available. The company just posted record Q1 2026 results with solid year-over-year growth in revenue, net income, and EPS, and analysts remain constructive despite a small price-target trim. The technical picture is still supportive, with positive MACD momentum and price trading near resistance after a strong run. Given the strong fundamentals and favorable Wall Street stance, I would rate it a buy now rather than waiting.
Price is 135.3001 after a sharp drop from the prior close of 178.9, but the broader setup remains constructive. MACD histogram is positive and expanding, which supports upside momentum. RSI_6 at 77.768 is elevated, showing the stock is extended in the short term, but the model still labels it neutral. Moving averages are converging, suggesting a transition phase rather than a breakdown. Key levels: pivot 176.727, resistance 183.435 and 187.579, support 170.019 and 165.875. The stock trend model suggests near-term softness but positive one-week and one-month follow-through.
["Record Q1 2026 earnings were reported.", "Revenue rose 10.35% YoY in Q1 2026.", "Net income increased 17.84% YoY in Q1 2026.", "EPS increased 18.75% YoY in Q1 2026.", "Q1 non-GAAP EPS of $4.74 beat expectations by $0.30.", "Analyst still maintains an Outperform rating.", "Options sentiment is neutral to mildly bullish."]
["Keefe Bruyette slightly lowered its price target from $219 to $215.", "RSI is elevated, implying the stock is short-term extended.", "Recent price action shows a sharp drop from the prior close.", "No strong hedge fund or insider buying trends were identified.", "No recent congress trading activity was reported."]
Latest quarter: Q1 2026. Financial performance was strong, with revenue increasing to $422.9M, up 10.35% YoY, net income rising to $51.8M, up 17.84% YoY, EPS increasing to $4.75, up 18.75% YoY, and gross margin improving to 25.62%, up 5.82% YoY. News also highlighted record Q1 2026 earnings, revenue around $110M, and core earnings of $52M, plus a non-GAAP EPS beat. The growth trend is clearly positive.
Recent analyst trend remains positive overall. Keefe Bruyette lowered the price target slightly to $215 from $219 but kept an Outperform rating, which is still bullish. This suggests Wall Street sees upside, though expectations were trimmed modestly. Net read: pros still favor the stock, with only a small con from the target reduction.
